The Lancet Haematology
Fecha de publicación: 09 october 2018
DOI: https://doi.org/10.1016/S2352-3026(18)30151-0
Autores: Elham E Amin, MD., Arina J ten Cate-Hoek, MD., Annemieke C Bouman, MD., Prof Karina Meijer, MD., Lidwine Tick, MD., Prof Saskia Middeldorp, MD., et al.
Background: The IDEAL DVT study showed that it was safe to shorten the duration of elastic compression therapy on an individualised basis after deep vein thrombosis for prevention of post-thrombotic syndrome. In this study, we assessed the cost-effectiveness of this strategy.
Comentarios
Para dejar un comentario antes debes iniciar sesión:
¿No tienes una cuenta?
Regístrate a través de éste enlace.